Eupraxia Pharmaceuticals Inc
(EPRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | |
| Operating Expenses | 3,537 | 0 |
| Operating Income | -3,537 | N/A |
| Interest Expense | 292 | 0 |
| Other Income | -128 | 0 |
| Pre-tax Income | -3,956 | 0 |
| Net Income Continuous | -3,956 | N/A |
| Minority Interests | -61 | N/A |
| Net Income | $-3,895 | $N/A |
| EPS Basic Total Ops | -0.18 | N/A |
| EPS Basic Continuous Ops | -0.18 | N/A |
| EPS Diluted Total Ops | -0.18 | N/A |
| EPS Diluted Continuous Ops | -0.18 | N/A |
| EBITDA(a) | $-3,499 | $N/A |